Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils. - Test2 - elhamkhani - TriplyDB

Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils.

Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils.

http://www.wikidata.org/entity/Q42951807

about

Regulation of neutrophil function by adenosine.Crosstalk between purinergic receptors and lipid mediators in leishmaniasis Lipoxins in chronic inflammation Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils.Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal.Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes Transfusion-related acute lung injury (TRALI): current concepts and misconceptions.Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.Immunoregulatory activity of adenosine and its role in human cancer progression.Purinergic signalling and immune cells.The Hypoxia-Adenosine Link during Inflammation.A cluster of immunoresolvents links coagulation to innate host defense in human blood.Purinergic signalling links mechanical breath profile and alveolar mechanics with the pro-inflammatory innate immune response causing ventilation-induced lung injury.Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils.Histamine-induced inhibition of leukotriene biosynthesis in human neutrophils: involvement of the H2 receptor and cAMP.Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.Arachidonic acid activates phospholipase D in human neutrophils; essential role of endogenous leukotriene B4 and inhibition by adenosine A2A receptor engagement.Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.Reprogramming of a subpopulation of human blood neutrophils by prolonged exposure to cytokines.Arachidonic acid regulates the translocation of 5-lipoxygenase to the nuclear membranes in human neutrophils.Effect of arachidonic acid reacylation on leukotriene biosynthesis in human neutrophils stimulated with granulocyte-macrophage colony-stimulating factor and formyl-methionyl-leucyl-phenylalanine.Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF.Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increases Systemic Inflammation and Cardiovascular Disease.Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues.

P2860

Q24620317-E24F0229-2230-443A-9025-11FE05782042 Q28072094-77324480-CD37-4EC8-B2B5-31A50C370A58 Q28196238-B912BA49-7C7A-4EF3-BCAD-F135C6A8FD53 Q33419375-0F1868F9-240D-482C-95C3-36BF397657A5 Q33836735-82A5D810-0CA0-47E8-8875-0E683311FB2A Q33940441-D2E9BAD6-1CF7-4C68-AAFC-7FE165C76BDE Q34162962-0D0718FC-D7E5-4005-9AB8-046837662BA9 Q35100910-1035F2A6-B784-4358-9998-656D7FFEDA72 Q36404222-A8DDB2DA-15EA-4BC0-A01C-E98F75C4184D Q37293340-FD310017-0CAD-4AEC-80C1-CCA2C1287273 Q38215678-AB26C495-EBAA-4626-8CDE-CE2B5D8D6E7C Q38263455-A25C3956-3BAB-49D0-A770-E19146C1AC9D Q38644137-D2421986-AFE7-4C72-8601-FAB09D2692C8 Q38647952-C30D334A-023E-49CE-986A-0BAE48286E91 Q39331944-3140D6D3-1A4E-4550-A1C6-4A4EC8D17D57 Q41446246-5517D329-159F-4A0A-90C5-A0908CF8B52C Q42083083-BAA578D8-5F00-4E03-A09C-5115FD8B9184 Q42370163-73FE4F1E-688B-4DF6-8B9A-0C87D5E08094 Q44378768-2011C0BE-CC0E-4672-8CA9-6A1CF6F5C37B Q44506981-F347C05E-640E-4237-8E71-630FB4808BD5 Q45918297-B61115F2-9BB9-4AD9-9DBF-7960AD44372E Q46794842-7495DE4D-0FB9-42CC-A4DF-157D92433A54 Q46958191-E2CF1346-0B05-4360-A85A-16038FE91795 Q46963143-8CB5176F-88AB-4654-A2B3-4A4C1C7D7EDD Q50043689-CBA70F24-7F28-4D8E-AB15-44C6AF21E404 Q52663243-3FB8DF96-5972-4249-9326-DF9ACAC91C2D

P2860

Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils.

http://www.wikidata.org/entity/Q42951807

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Suppression of leukotriene B4 ...... d-activated human neutrophils.

@en

Suppression of leukotriene B4 ...... d-activated human neutrophils.

@nl

type

label

Suppression of leukotriene B4 ...... d-activated human neutrophils.

@en

Suppression of leukotriene B4 ...... d-activated human neutrophils.

@nl

prefLabel

Suppression of leukotriene B4 ...... d-activated human neutrophils.

@en

Suppression of leukotriene B4 ...... d-activated human neutrophils.

@nl

P1433

Q42951807-BF772D27-2465-4A41-BF51-CF5BA63B1A2B

P1476

Q42951807-72F4004E-1741-4EC4-8E00-780851320397

P2093

Q42951807-0F7AFD71-2C4C-4645-981B-7233DCEFE02A

Q42951807-18FF2CE2-3D74-4215-8878-BC5FC8FDA983

Q42951807-614FE6D2-2F59-4A93-888D-E7E329B649FD

Q42951807-C3B3CC41-DF66-4D07-B9FB-4A90242894CE

P2860

Q42951807-03350522-DDFD-4431-A5E4-E28EE668FCD4

Q42951807-093FC153-D7C2-44AE-BE12-4D7683566ED3

Q42951807-1A0827BF-B8D0-4052-AF5A-047196E092B9

Q42951807-22915887-2193-440B-8058-79DCA1102651

Q42951807-2BE9265F-3161-43A9-B857-A4434B585496

Q42951807-51090080-D379-4E39-B9EF-574308E13294

Q42951807-5E795F05-DD0C-4C5F-904A-57DBCF8330A8

Q42951807-9A047569-FDF2-4003-9E32-F22A5344F385

Q42951807-9AC93AAD-9CE1-486D-9E15-5693545C4551

Q42951807-A327C97F-32F0-4E27-8D55-623BDCA6F216

P304

Q42951807-A7D4AAFD-AED2-4CEA-9FCB-FA81BD917544

P31

Q42951807-641B1FFC-CBA3-4EF6-B550-550D99D039B8

P356

Q42951807-64E19D18-9466-49CA-A632-5F1F05993B3B

P407

Q42951807-1C9FB828-A796-4861-9711-784A99956AEC

P433

Q42951807-F03DA8BD-497A-4009-9129-0FE8771B2942

P478

Q42951807-88F35B6B-E9AF-4735-8DD2-ACFEEFEC31BC

P577

Q42951807-F4CC8680-D4F0-4439-8C02-36A7C0CEF321

P5875

Q42951807-A26D17A2-A9B3-45BF-8BB6-BF90B40EC1B8

P698

Q42951807-B9946C28-0D2A-49B0-98E9-91ADE0C66888

P932

Q42951807-2FA27C08-24DF-4F5C-88B4-CB9FB5DDBD06

P356

P1433

Journal of Experimental Medicine

P1476

Suppression of leukotriene B4 ...... d-activated human neutrophils.

@en

P2093

E Krump

http://www.w3.org/2001/XMLSchema#string

J Mancini

http://www.w3.org/2001/XMLSchema#string

P Borgeat

http://www.w3.org/2001/XMLSchema#string

S Picard

http://www.w3.org/2001/XMLSchema#string

P2860

Purine catabolism in polymorphonuclear neutrophils. Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase.

Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro.

Leukotriene B4 in the immune system.

Erythrocyte-neutrophil interactions: formation of leukotriene B4 by transcellular biosynthesis.

8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo.

Functional characterization of three adenosine receptor types

Biosynthesis and biological activity of leukotriene B4.

Turnover of adenosine in plasma of human and dog blood.

Adenosine, an endogenous anti-inflammatory agent.

Transcellular biosynthesis of leukotrienes and lipoxins via leukotriene A4 transfer.

P304

1401-1406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.186.8.1401

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

1997-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13893761

http://www.w3.org/2001/XMLSchema#string

P698

9334381

http://www.w3.org/2001/XMLSchema#string

P932

2199092

http://www.w3.org/2001/XMLSchema#string